Navigation Links
Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab
Date:8/3/2009

BETHESDA, Md., Aug. 3 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it has received Orphan Drug Designation from the European Medicines Agency (EMEA) for BiTE antibody blinatumomab (MT103) for acute lymphoblastic leukemia (ALL). Blinatumomab is a novel therapeutic antibody that activates a patient's T cells to seek out and destroy cancer cells.

In June, Micromet announced that the company had achieved its primary endpoint in an ongoing Phase 2 study of ALL patients. The company presented data at the the 14(th) Congress of the European Hematology Association (EHA) in Berlin, Germany, showing an 81% response rate in acute lymphoblastic leukemia (ALL) patients with minimal residual disease (MRD)(1).

The patients included in this phase 2 clinical trial were in complete hematological remission following intense chemotherapy regimens, but retained a detectable level of ALL cancer cells in their bone marrow - so called minimal residual disease (MRD). Various studies have confirmed that ALL patients with MRD following chemotherapy have a significantly worse prognosis than patients without MRD.

According to the EMEA, "orphan" medicinal products are intended for the diagnosis, prevention or treatment of life-threatening or chronically debilitating conditions that affect no more than five in 10,000 people in the European Union, or are medicines which, for economic reasons, would be unlikely to be developed without incentives.

The aim of the EU legislative framework for orphan medicines is to stimulate research and development of medicinal products for rare diseases by providing incentives to the pharmaceutical industry suc
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Micromet Announces Pricing of Public Offering of Common Stock
2. Micromet Announces Public Offering of Common Stock
3. Micromet, Inc. to Host Conference Call and Webcast to Report Second Quarter 2009 Financial Results on August 6, 2009
4. Micromet Added to Russell 3000 Index
5. Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8, 2009
6. Micromet Presents Update at ASCO 2009 on a Phase 1b Combination Study of Adecatumumab and Docetaxel
7. Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO
8. Micromet, Inc. to Host Conference Call and Webcast to Report First Quarter 2009 Financial Results on May 6, 2009
9. Micromet Presents Data at AACR Meeting Showing Elimination of Colorectal Cancer Stem Cells by BiTE Antibody MT110
10. Micromet to Present at the Future Leaders in the Biotech Industry Conference on April 2, 2009
11. Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...mber24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NA...ompany,today,announcedthatithassubmittedaMAAtotheE...pany,senzymereplacementtherapyindevelopment,forthe...ting,applicationforvelaglucerasealfathathasbeensub...dCanada. , Basedonaglobalsupplyshortageofthec...
(Date:11/24/2009)... Program Connects Customers with Partners Va...ith DNA Genotek Products , ...otek , a leading provider of products for biologic...n, today announced its new global partner program....NA Genotek,s partner community and is designed to ...
(Date:11/23/2009)...You can think of it as origami very high-tech ori... have developed a technique for fabricating three-... from thin films by coupling photolithography and ...tions. , The films, only a few microns thick, off...h thicker pieces of the same material. , "This is...
(Date:11/23/2009)...,ON,Nov.23/PRNewswire-FirstCall/-YMBioSciencesInc....pmentcompanythatidentifiesandadvancesadiverseportf...esofdevelopment,todayreportedthatCytopia(ASX:CYT)h...T387,apotent,orally-administeredJAK1/JAK2inhibitor...innesota.AproposaltomergeCytopiaintoYMhasbeenprevi...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
...t International Shock Congress by sepsis thought ...June 26 /PRNewswire-FirstCall/ - Spectral Diagnost...on of data that demonstrates the,combined clinical...A(TM)),the only FDA cleared diagnostic for the mea...levated endotoxin levels and to guide endotoxin,re...
... U.S. Ag, LLC of Luthersville, GA has the attent...ith the creation of a revolutionary new formula th...ge in the high moisture range without spoilage, ro...Luthersville, GA (PRWEB) June 24, 2008 -- U.S. Ag,...le feeders and dairymen industry wide with the cre...
...25 Cell Biosciences, Inc., a,provider of ultrasen...ems,to life science researchers, today announced t... Tim Harkness was named President and Chief Execut...was the Chief Financial Officer for Molecular,Devi...into a global leader,in life science research tool...
Other Biology Technology:Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics 2Breakthrough Slashes $7 Corn Over Half for Cattle Feeders 2Breakthrough Slashes $7 Corn Over Half for Cattle Feeders 3Cell Biosciences Announces New Leadership 2
(Date:11/23/2009)...ts strong evidence that the "synergistic" effect o...ted pollution and indoor endotoxin causes more har...re alone. , Environmental health scientists at...cine have shown that children exposed to both high...dotoxin during early life are six times more likel...
(Date:11/23/2009)...- The time of day matters to forest trees dealing ... a research team led by Professor Malcolm Campbell...al for research and colleagues in the department o...s. , Capitalizing on their previous work to de...eam examined how poplar trees use their 45,000 gen...
(Date:11/23/2009)...rch suggests that a common oral bacterium may exac...Nichols et al, "Unique Lipids from a Common Human ...pable of Enhancing Autoimmunity," appears in the D...hology . , Multiple sclerosis (MS), a disease wh... cord, affects nearly 1 in 700 people in the Unite...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Haemonetics Signs Comprehensive Agreement with Blood Centers of America 57334 1Haemonetics Signs Comprehensive Agreement with Blood Centers of America 57334 2Shockwave Treatment May Not Be Best for Shoulder Pain 57330 1Shockwave Treatment May Not Be Best for Shoulder Pain 57330 2Breast Health and Healing Foundation Convenes Groundbreaking Breast Cancer Summit in Washington D C On October 9 2009 57327 1Breast Health and Healing Foundation Convenes Groundbreaking Breast Cancer Summit in Washington D C On October 9 2009 57327 2Breast Health and Healing Foundation Convenes Groundbreaking Breast Cancer Summit in Washington D C On October 9 2009 57327 3
...rauma patients, every second counts. Yet bruises, ... difficult to locate veins and administer lifesavi...orgia Institute of Technology researchers is devel...ppler ultrasound technology to find veins quickly....vessel detection," says project leader Michael Gra...
... and extreme athletes, lactic acid is poison, a wa...s to muscle fatigue, reduced performance and pain....California, Berkeley, however, tells a different s...nd athletes don,t realize it, says exercise physio...egrative biology, but endurance training teaches t...
...sweet lure of chocolate or the bitter taste of str...responses be so innate as to be hard-wired into th...lable fruit fly Drosophila, Kristin Scott and coll...Neuron experiments demonstrating just such a hard-...r a model for taste encoding in the brain that hol...
Other Biology News:Researchers develop portable 'vein finder' for faster, more accurate injections 2Researchers develop portable 'vein finder' for faster, more accurate injections 3Lactic acid not athlete's poison, but an energy source - if you know how to use it 2Lactic acid not athlete's poison, but an energy source - if you know how to use it 3Lactic acid not athlete's poison, but an energy source - if you know how to use it 4How taste response is hard-wired into the brain 2
...-up, these culture chambers produce cell yields in...s to multiple roller bottles or spinner flasks. &b...l integrity • 100% leak tested prior to shipp...y gamma irradiation, with low particulate contamin...
Taq DNA Polymerase (with KCl buffer) from ABgene
Buffer for sal I 10X (do not list in catalog) BLACK (Sal I) from Sigma-Aldrich
... thermostable DNA polymerase obtained by high leve...coli, Concentration: 5U/ul, Applications: Standard...world leader in serving science. Thermo Fisher Sci...ier, cleaner and safer by providing analytical ins...
Biology Products: